Serum Tenascin-C is independently associated with increased major adverse cardiovascular events and death in patients with type II diabetes
ConclusionsIn patients with type 2 diabetes, we show for the first time that increased serum TNC concentrations are independently associated with MACE and death. These findings suggest that elevated TNC expression might be implicated in the increased CV risk associated with diabetes, and might be useful for CV risk stratification in this context.
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Heart Attack | Heart Failure | Hypertension | Smokers | Stroke